Emilien Chabrillac1,2, Sylvain Morinière3, Franck Jegoux4, David Blanchard5, Olivier Choussy6, Stéphane Hans1,2, Sébastien Vergez7. 1. Department of Ear, Nose, and Throat - Head and Neck Surgery, Toulouse University Hospital, Hôpital Larrey, Toulouse, France. 2. Department of Surgery, University Cancer Institute Toulouse, Toulouse, France. 3. Department of Ear, Nose, and Throat - Head and Neck Surgery, Tours University Hospital, Cedex, France. 4. Department of Ear, Nose, and Throat - Head and Neck Surgery, Rennes University Hospital, Rennes, France. 5. Department of Ear, Nose, and Throat - Head and Neck Surgery, Institut Curie Hospital, Paris, France. 6. Department of Ear, Nose, and Throat - Head and Neck Surgery, Rouen University Hospital, Rouen, France. 7. Department of Ear, Nose, and Throat - Head and Neck Surgery, Georges Pompidou European Hospital, Paris, France.
Abstract
BACKGROUND: The purpose of this study was to assess the current use of transoral robotic surgery (TORS) in benign tumors of the upper aerodigestive tract through a case series and a literature review. METHODS: This multicentric retrospective study was conducted in 6 French centers between November 2009 and July 2017. RESULTS: Twenty-one patients had a TORS resection of a tumor at varied locations with differing histopathologic characteristics. The mean postoperative hospital stay was 6.1 days. Eight patients had nasogastric tubes, which were removed after a mean of 5.6 days. Two patients had a prophylactic tracheostomy for an average of 5.5 days. A third tracheostomy was performed secondarily for postoperative bleeding. No recurrences were observed during the 2-year follow-up. CONCLUSION: This technique caused few complications and resulted in short hospitalization, with satisfactory functional and recurrence outcomes. However, the risk of bleeding and edema must be considered, and the need for a tracheostomy must be approached wisely.
BACKGROUND: The purpose of this study was to assess the current use of transoral robotic surgery (TORS) in benign tumors of the upper aerodigestive tract through a case series and a literature review. METHODS: This multicentric retrospective study was conducted in 6 French centers between November 2009 and July 2017. RESULTS: Twenty-one patients had a TORS resection of a tumor at varied locations with differing histopathologic characteristics. The mean postoperative hospital stay was 6.1 days. Eight patients had nasogastric tubes, which were removed after a mean of 5.6 days. Two patients had a prophylactic tracheostomy for an average of 5.5 days. A third tracheostomy was performed secondarily for postoperative bleeding. No recurrences were observed during the 2-year follow-up. CONCLUSION: This technique caused few complications and resulted in short hospitalization, with satisfactory functional and recurrence outcomes. However, the risk of bleeding and edema must be considered, and the need for a tracheostomy must be approached wisely.